ReNAgade Therapeutics
About:
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.
Website: https://renagadetx.com
Twitter/X: ReNAgadeTx
Top Investors: MPM Capital, F2 Ventures
Description:
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications.
Total Funding Amount:
$300M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2021-01-01
Contact Email:
info(AT)renagadetx.com
Founders:
Brian Goodman
Number of Employees:
101-250
Last Funding Date:
2023-05-23
IPO Status:
Private
© 2025 bioDAO.ai